Nanogen Pharmaceutical Biotechnology JSC
Records under this name other than the patents Nanogen Pharmaceutical Biotechnology JSC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 2 of 2 · Back to Nanogen Pharmaceutical Biotechnology JSC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,980,245 | PEG-interferon λ1 conjugates and methods of treating viral infections Lapsed on the fee record Ended Mar 17, 2023 · USPTO record | Lapsed on the fee record | Ended Mar 17, 2023 | USPTO record |
| US 8,454,947 | PEG-interferon lambda 1 conjugates Lapsed on the fee record Ended Jun 4, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 4, 2021 | USPTO record |